fda warning peptides bpc-157 not approved for human use news peptide A closer look at the unapproved injections What to Know About – An FDA advisory committee is

Lyophilized (freeze-dried) peptides must be protected from temperature fluctuations, moisture, and light exposure from the moment of synthesis to final delivery

The preservative in bacteriostatic water, benzyl alcohol at 0.9% concentration, remains stable for up to 120 days with only minor concentration declines

Injection: Do NOT aspirate for subcutaneous injections

Based on current information, well outline how to estimate BPC-157 dosage in various experimental settings

Start: 2.5 mg once daily to assess tolerance

None of these tissue-specific claims rest on 20232026 musculoskeletal randomised controlled trials (RCTs), so the selection logic below is preclinical extrapolation rather than confirmed human efficacy [5][6][9]